Invokana (canagliflozin) is a prescription medication used to manage type 2 diabetes by helping patients regulate their blood sugar levels. It belongs to a class of drugs called SGLT2 inhibitors, which work by preventing the kidneys from reabsorbing glucose, leading to its removal through urine. This medication is often recommended when other treatments like diet and exercise alone do not sufficiently control blood sugar.
The key mechanism behind Invokana is its ability to block sodium-glucose co-transporter 2 (SGLT2) in the kidneys. By inhibiting this protein, the medication reduces glucose reabsorption and promotes the excretion of excess sugar. This unique approach complements insulin-independent glucose management, making it a helpful option for people with insulin resistance.
In addition to improving glycemic control, Invokana provides other health benefits. Research has shown that it can also reduce the risk of cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes. Furthermore, the drug helps with weight loss and reduces blood pressure, offering additional advantages beyond blood sugar regulation.
Like any medication, Invokana comes with potential side effects. Some common issues include urinary tract infections, increased urination, and thirst. In rare cases, serious side effects, such as ketoacidosis (a dangerous increase in ketone levels) or amputations, may occur. It's important to follow your healthcare provider’s instructions and report any unusual symptoms promptly.
Before starting Invokana, patients should consult their doctor to assess whether it's the right fit for them. Those with a history of kidney disease, dehydration, or prone to infections may need to explore other options. A healthcare professional can also guide patients on dosage and help monitor any side effects or interactions with other medications they might be taking.
Related Articles
Sep 18, 2024 at 3:27 AM
Aug 28, 2024 at 6:48 AM
Oct 15, 2024 at 3:53 AM
Sep 20, 2024 at 6:54 AM
Sep 19, 2024 at 3:13 AM
May 22, 2024 at 3:19 AM
Sep 11, 2024 at 7:50 AM
Aug 20, 2024 at 4:12 PM
Aug 30, 2024 at 6:58 AM
Aug 27, 2024 at 11:07 AM
Always seek the advice of a qualified professional in relation to any specific problem or issue. The information provided on this site is provided "as is" without warranty of any kind, either express or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, or non-infringement. The owners and operators of this site are not liable for any damages whatsoever arising out of or in connection with the use of this site or the information contained herein.
2023 Copyright. All Rights Reserved.